Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vexev has developed an AI-powered autonomous ultrasound platform ("VxWave") that enables non-specialists to perform high-quality vascular scans. Clinical trials with US Renal Care demonstrated over a 96% success rate for in-center scans performed by existing dialysis staff. The company’s tomographic ultrasound robot produces advanced 3D images comparable to MRI/CT but at lower cost and higher accessibility. Their mission focuses on improving early detection and management of cardiovascular diseases, especially among high-risk populations such as those undergoing dialysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vexev.